Brent Warner Poseida Therapeutics, Inc. (PSTX) insider trading activity

PSTX Quotes by TradingView

Brent Warner is President, Gene Therapy of Poseida Therapeutics, Inc.. Currently has a direct ownership of 419,040 shares of PSTX, which is worth approximately $3.96 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 35,739 shares (Common Stock) at a price of $4.13 per share, resulting in proceeds of $147,602. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 419K
0% 3M change
12.03% 12M change
Total Value Held $3.96 Million

Brent Warner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
SELL
Payment of exercise price or tax liability
$147,602 $4.13 p/Share
35,739 Reduced 7.86%
419,040 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
80,743 Added 15.08%
454,779 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$142,400 $5.35 p/Share
26,617 Reduced 6.64%
374,036 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
92,772 Added 18.8%
400,653 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
307,881 Added 50.0%
307,881 Common Stock
BW

Brent Warner

President, Gene Therapy
San Diego, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PSTX